Arrevus Secures Support from the North Carolina Biotechnology Center to Advance ARV-1801 for the Treatment of Pulmonary Exacerbations in Cystic Fibrosis Patients...
RALEIGH, N.C.--(BUSINESS WIRE)--Oct 30, 2019--
RALEIGH, N.C.--(BUSINESS WIRE)--Oct 30, 2019--